Showing results (1-10 of 189) with videos related to
Sort By:
Pageof 19
Health and Quality of Life Outcomes|March 28, 2006
Comparison of the SF-6D and the EQ-5D in patients with coronary heart diseaseHenk F van Stel, Erik BuskensNicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 21, 2023
Cost-Effectiveness of Four Tobacco Control Interventions in MongoliaAriuntuya Tuvdendorj, Talitha Feenstra, Erik BuskensMedical Decision Making : an International Journal of the Society for Medical Decision Making|January 17, 2009
Do intraindividual variation in disease progression and the ensuing tight window of opportunity affect estimation of screening benefits?Hendrik Koffijberg, Gabriel Rinkel, Erik BuskensInternational Journal of Nursing Studies|April 20, 2006
The prevalence and incidence of pressure ulcers in hospitalised patients in the Netherlands: a prospective inception cohort studyLisette Schoonhoven, Mente T Bousema, Erik Buskens, et al.Biomed Research International|October 24, 2015
Using multicriteria decision analysis to support research priority setting in biomedical translational research projectsGimon de Graaf, Douwe Postmus, Erik BuskensParkinsonism & Related Disorders|April 7, 2022
Letter to the editor, "Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications"Harmen R Moes, Erik Buskens, Teus van LaarPlos One|February 15, 2020
Smoking-attributable burden of lung cancer in Mongolia a data synthesis study on differences between men and womenAriuntuya Tuvdendorj, Talitha Feenstra, Badamsuren Tseveen, et al.International Journal of Health Policy and Management|October 12, 2021
Factors Influencing Procurement of Digital Healthcare: A Case Study in Dutch District NursingSander Holterman, Marike Hettinga, Erik Buskens, et al.BMC Neurology|June 5, 2024
Comment on "Does the 5-2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries"Harmen R Moes, Erik Buskens, Teus van LaarPharmacoeconomics|April 7, 2018
Head-to-Head Comparison of EQ-5D-3L and EQ-5D-5L Health ValuesAnna Selivanova, Erik Buskens, Paul F M KrabbePageof 19